nodes	percent_of_prediction	percent_of_DWPC	metapath
Sotalol—Haemorrhage—Fludarabine—lymphatic system cancer	0.0055	0.0055	CcSEcCtD
Sotalol—Amnesia—Carmustine—lymphatic system cancer	0.00541	0.00541	CcSEcCtD
Sotalol—Visual impairment—Fludarabine—lymphatic system cancer	0.0053	0.0053	CcSEcCtD
Sotalol—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00524	0.00524	CcSEcCtD
Sotalol—Bronchospasm—Bleomycin—lymphatic system cancer	0.00495	0.00495	CcSEcCtD
Sotalol—Arrhythmia—Fludarabine—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Sotalol—Leukopenia—Teniposide—lymphatic system cancer	0.00487	0.00487	CcSEcCtD
Sotalol—Alopecia—Fludarabine—lymphatic system cancer	0.00486	0.00486	CcSEcCtD
Sotalol—Pain in extremity—Vincristine—lymphatic system cancer	0.00485	0.00485	CcSEcCtD
Sotalol—Cardiac failure—Mitoxantrone—lymphatic system cancer	0.00484	0.00484	CcSEcCtD
Sotalol—Hypertension—Teniposide—lymphatic system cancer	0.0047	0.0047	CcSEcCtD
Sotalol—Paralysis—Methotrexate—lymphatic system cancer	0.00467	0.00467	CcSEcCtD
Sotalol—Chest pain—Teniposide—lymphatic system cancer	0.00464	0.00464	CcSEcCtD
Sotalol—Oedema—Teniposide—lymphatic system cancer	0.00444	0.00444	CcSEcCtD
Sotalol—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00443	0.00443	CcSEcCtD
Sotalol—Infection—Teniposide—lymphatic system cancer	0.00441	0.00441	CcSEcCtD
Sotalol—Myocardial infarction—Bleomycin—lymphatic system cancer	0.0044	0.0044	CcSEcCtD
Sotalol—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Sotalol—Hyperhidrosis—Teniposide—lymphatic system cancer	0.0043	0.0043	CcSEcCtD
Sotalol—Leukopenia—Fludarabine—lymphatic system cancer	0.00428	0.00428	CcSEcCtD
Sotalol—Pruritus—Mechlorethamine—lymphatic system cancer	0.00426	0.00426	CcSEcCtD
Sotalol—Cough—Fludarabine—lymphatic system cancer	0.00418	0.00418	CcSEcCtD
Sotalol—Hypotension—Teniposide—lymphatic system cancer	0.00415	0.00415	CcSEcCtD
Sotalol—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00412	0.00412	CcSEcCtD
Sotalol—Myalgia—Fludarabine—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Sotalol—Haemoglobin—Bleomycin—lymphatic system cancer	0.00405	0.00405	CcSEcCtD
Sotalol—Haemorrhage—Bleomycin—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Sotalol—Hyperglycaemia—Carmustine—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Sotalol—Dyspnoea—Teniposide—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Sotalol—Depression—Carmustine—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Sotalol—Oedema—Fludarabine—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Sotalol—Infection—Fludarabine—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Sotalol—Decreased appetite—Teniposide—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Sotalol—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Sotalol—Vomiting—Mechlorethamine—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Sotalol—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Sotalol—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Sotalol—Rash—Mechlorethamine—lymphatic system cancer	0.0038	0.0038	CcSEcCtD
Sotalol—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.0038	0.0038	CcSEcCtD
Sotalol—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0038	0.0038	CcSEcCtD
Sotalol—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00378	0.00378	CcSEcCtD
Sotalol—Depression—Vincristine—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Sotalol—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Sotalol—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Sotalol—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00367	0.00367	CcSEcCtD
Sotalol—Myocardial infarction—Vincristine—lymphatic system cancer	0.00367	0.00367	CcSEcCtD
Sotalol—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Sotalol—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00363	0.00363	CcSEcCtD
Sotalol—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Sotalol—Nausea—Mechlorethamine—lymphatic system cancer	0.00358	0.00358	CcSEcCtD
Sotalol—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Sotalol—Alopecia—Bleomycin—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Sotalol—Haemoglobin—Carmustine—lymphatic system cancer	0.00354	0.00354	CcSEcCtD
Sotalol—Haemorrhage—Carmustine—lymphatic system cancer	0.00352	0.00352	CcSEcCtD
Sotalol—Abdominal pain—Teniposide—lymphatic system cancer	0.00351	0.00351	CcSEcCtD
Sotalol—Body temperature increased—Teniposide—lymphatic system cancer	0.00351	0.00351	CcSEcCtD
Sotalol—Paraesthesia—Fludarabine—lymphatic system cancer	0.00351	0.00351	CcSEcCtD
Sotalol—Dyspnoea—Fludarabine—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Sotalol—Dyspepsia—Fludarabine—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Sotalol—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Sotalol—Decreased appetite—Fludarabine—lymphatic system cancer	0.00339	0.00339	CcSEcCtD
Sotalol—Visual impairment—Carmustine—lymphatic system cancer	0.00339	0.00339	CcSEcCtD
Sotalol—Fatigue—Fludarabine—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Sotalol—Pain—Fludarabine—lymphatic system cancer	0.00334	0.00334	CcSEcCtD
Sotalol—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Sotalol—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00329	0.00329	CcSEcCtD
Sotalol—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Sotalol—Asthenia—Teniposide—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Sotalol—Pruritus—Teniposide—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Sotalol—Arrhythmia—Carmustine—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Sotalol—Leukopenia—Bleomycin—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Sotalol—Alopecia—Carmustine—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Sotalol—Body temperature increased—Fludarabine—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Sotalol—Cough—Bleomycin—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Sotalol—Angiopathy—Vincristine—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Sotalol—Diarrhoea—Teniposide—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Sotalol—Chest pain—Bleomycin—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Sotalol—Myalgia—Bleomycin—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Sotalol—Alopecia—Vincristine—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Sotalol—Back pain—Carmustine—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Sotalol—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Sotalol—Alopecia—Mitoxantrone—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Sotalol—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Sotalol—Vision blurred—Carmustine—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Sotalol—Oedema—Bleomycin—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Sotalol—Infection—Bleomycin—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Sotalol—Back pain—Vincristine—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Sotalol—Vomiting—Teniposide—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Sotalol—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Sotalol—Asthenia—Fludarabine—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Sotalol—Rash—Teniposide—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Sotalol—Dermatitis—Teniposide—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Sotalol—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Sotalol—Headache—Teniposide—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Sotalol—Pruritus—Fludarabine—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Sotalol—Back pain—Mitoxantrone—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Sotalol—Leukopenia—Carmustine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Sotalol—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Sotalol—Hypotension—Bleomycin—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Sotalol—Diarrhoea—Fludarabine—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Sotalol—Hypertension—Carmustine—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Sotalol—Nausea—Teniposide—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Sotalol—Vertigo—Vincristine—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Sotalol—Leukopenia—Vincristine—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Sotalol—Myalgia—Carmustine—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Sotalol—Chest pain—Carmustine—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Sotalol—Anxiety—Carmustine—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Sotalol—Paraesthesia—Bleomycin—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Sotalol—Dyspnoea—Bleomycin—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Sotalol—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Sotalol—Hypertension—Vincristine—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Sotalol—Oedema—Carmustine—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Sotalol—Decreased appetite—Bleomycin—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Sotalol—Myalgia—Vincristine—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Sotalol—Visual disturbance—Methotrexate—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Sotalol—Cough—Mitoxantrone—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Sotalol—Infection—Carmustine—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Sotalol—Vomiting—Fludarabine—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Sotalol—Rash—Fludarabine—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Sotalol—Dermatitis—Fludarabine—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Sotalol—Hypertension—Mitoxantrone—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Sotalol—Pain—Bleomycin—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Sotalol—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Sotalol—Headache—Fludarabine—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Sotalol—Chest pain—Mitoxantrone—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Sotalol—Myalgia—Mitoxantrone—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Sotalol—Anxiety—Mitoxantrone—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Sotalol—Lethargy—Methotrexate—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Sotalol—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Sotalol—Oedema—Vincristine—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Sotalol—Infection—Vincristine—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Sotalol—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Sotalol—Hypotension—Carmustine—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Sotalol—Oedema—Mitoxantrone—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Sotalol—Nausea—Fludarabine—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Sotalol—Infection—Mitoxantrone—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Sotalol—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Sotalol—Shock—Mitoxantrone—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Sotalol—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Sotalol—Body temperature increased—Bleomycin—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Sotalol—Insomnia—Carmustine—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Sotalol—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Sotalol—Paraesthesia—Carmustine—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Sotalol—Mood swings—Methotrexate—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Sotalol—Hypotension—Vincristine—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Sotalol—Dyspnoea—Carmustine—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Sotalol—Somnolence—Carmustine—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Sotalol—Decreased appetite—Carmustine—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Sotalol—Hypotension—Mitoxantrone—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Sotalol—Insomnia—Vincristine—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Sotalol—Paraesthesia—Vincristine—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Sotalol—Pain—Carmustine—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Sotalol—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Sotalol—Decreased appetite—Vincristine—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Sotalol—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Sotalol—Somnolence—Mitoxantrone—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Sotalol—Fatigue—Vincristine—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Sotalol—Asthenia—Bleomycin—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Sotalol—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Sotalol—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Sotalol—Pain—Vincristine—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Sotalol—Asthma—Methotrexate—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Sotalol—Pruritus—Bleomycin—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Sotalol—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Sotalol—Eosinophilia—Methotrexate—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Sotalol—Fatigue—Mitoxantrone—lymphatic system cancer	0.002	0.002	CcSEcCtD
Sotalol—Pain—Mitoxantrone—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Sotalol—Abdominal pain—Carmustine—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Sotalol—Body temperature increased—Carmustine—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Sotalol—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Sotalol—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Sotalol—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Sotalol—Abdominal pain—Vincristine—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Sotalol—Body temperature increased—Vincristine—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Sotalol—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Sotalol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Sotalol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Sotalol—Vomiting—Bleomycin—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Sotalol—Drowsiness—Methotrexate—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Sotalol—Depression—Methotrexate—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Sotalol—Rash—Bleomycin—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Sotalol—Dermatitis—Bleomycin—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Sotalol—Asthenia—Carmustine—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Sotalol—Asthenia—Vincristine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Sotalol—Diarrhoea—Carmustine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Sotalol—Nausea—Bleomycin—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Sotalol—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Sotalol—Asthenia—Mitoxantrone—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Sotalol—Dizziness—Carmustine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Sotalol—Haemoglobin—Methotrexate—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Sotalol—Diarrhoea—Vincristine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Sotalol—Haemorrhage—Methotrexate—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Sotalol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Sotalol—Vomiting—Carmustine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Sotalol—Dizziness—Vincristine—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Sotalol—Rash—Carmustine—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Sotalol—Dermatitis—Carmustine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Sotalol—Visual impairment—Methotrexate—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Sotalol—Headache—Carmustine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Sotalol—Vomiting—Vincristine—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Sotalol—Rash—Vincristine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Sotalol—Dermatitis—Vincristine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Sotalol—Headache—Vincristine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Sotalol—Nausea—Carmustine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Sotalol—Angiopathy—Methotrexate—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Sotalol—Vomiting—Mitoxantrone—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Sotalol—Rash—Mitoxantrone—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Sotalol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Sotalol—Headache—Mitoxantrone—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Sotalol—Alopecia—Methotrexate—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Sotalol—Nausea—Vincristine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Sotalol—Dysgeusia—Methotrexate—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Sotalol—Nausea—Mitoxantrone—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Sotalol—Back pain—Methotrexate—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Sotalol—Vision blurred—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Sotalol—Vertigo—Methotrexate—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Sotalol—Leukopenia—Methotrexate—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Sotalol—Cough—Methotrexate—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Sotalol—Chest pain—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Sotalol—Myalgia—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Sotalol—Infection—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Sotalol—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Sotalol—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Sotalol—Hypotension—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Sotalol—Insomnia—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Sotalol—Paraesthesia—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Sotalol—Dyspnoea—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Sotalol—Somnolence—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Sotalol—Dyspepsia—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Sotalol—Decreased appetite—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Sotalol—Fatigue—Methotrexate—lymphatic system cancer	0.000998	0.000998	CcSEcCtD
Sotalol—Pain—Methotrexate—lymphatic system cancer	0.00099	0.00099	CcSEcCtD
Sotalol—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000947	0.000947	CcSEcCtD
Sotalol—Abdominal pain—Methotrexate—lymphatic system cancer	0.000915	0.000915	CcSEcCtD
Sotalol—Body temperature increased—Methotrexate—lymphatic system cancer	0.000915	0.000915	CcSEcCtD
Sotalol—Asthenia—Methotrexate—lymphatic system cancer	0.000831	0.000831	CcSEcCtD
Sotalol—Pruritus—Methotrexate—lymphatic system cancer	0.000819	0.000819	CcSEcCtD
Sotalol—Diarrhoea—Methotrexate—lymphatic system cancer	0.000792	0.000792	CcSEcCtD
Sotalol—Dizziness—Methotrexate—lymphatic system cancer	0.000766	0.000766	CcSEcCtD
Sotalol—Vomiting—Methotrexate—lymphatic system cancer	0.000736	0.000736	CcSEcCtD
Sotalol—Rash—Methotrexate—lymphatic system cancer	0.00073	0.00073	CcSEcCtD
Sotalol—Dermatitis—Methotrexate—lymphatic system cancer	0.000729	0.000729	CcSEcCtD
Sotalol—Headache—Methotrexate—lymphatic system cancer	0.000725	0.000725	CcSEcCtD
Sotalol—Nausea—Methotrexate—lymphatic system cancer	0.000688	0.000688	CcSEcCtD
